IVF injections cause a predictable set of side effects, most of them mild and temporary. The most common are bloating, headaches, breast tenderness, mood swings, fatigue, and soreness at the injection site. These are driven by the rapid rise in hormone levels as your ovaries are stimulated to grow multiple eggs at once, and they typically resolve within a week after the egg retrieval procedure.
What Happens in Your Body During Stimulation
In a natural cycle, your ovaries develop one mature egg. IVF medications push them to recruit and grow many follicles simultaneously, which causes estrogen levels to climb far higher than normal. Your ovaries physically enlarge during this process, sometimes to several times their usual size. That combination of elevated hormones and swollen ovaries is what produces most of the side effects you’ll feel.
Stimulation typically lasts 8 to 14 days. Side effects tend to be mild at first and become increasingly noticeable as you approach egg retrieval. After the retrieval, the ovaries generally return to their original size within 5 to 7 days, and most symptoms fade in that same window.
Common Physical Side Effects
Bloating and pelvic pressure are nearly universal. As your ovaries enlarge, you’ll feel fullness in your lower abdomen that can range from mildly uncomfortable to genuinely distracting. Clothes may feel tighter around the waist, and some people describe feeling like they’ve eaten a large meal that won’t digest.
Headaches and fatigue are reported frequently during the stimulation phase and are tied to the hormonal shifts your body is processing. Breast tenderness shows up as estrogen rises, and it often intensifies later in the cycle when progesterone support begins after egg retrieval. Progesterone also commonly causes constipation and sleepiness.
Vaginal spotting can occur, particularly after the first injection of certain medications. This happens because the sudden change in estrogen disrupts the uterine lining. It’s typically light and brief.
Injection Site Reactions
Since IVF involves daily subcutaneous injections (usually in the belly or thigh) for the entire stimulation phase, local skin reactions are common. The most frequent are redness around the injection site, mild pain or stinging during and after the shot, itching, and occasional swelling. Bruising is less common but happens, especially if a small blood vessel is nicked.
Rare cases involve small lumps under the skin (subcutaneous nodules) that can take weeks to fully resolve. Sterile abscess formation has been documented but is uncommon, occurring in well under 1% of patients in studies tracking the complication. Rotating injection sites from day to day and allowing the medication to reach room temperature before injecting can reduce discomfort.
Mood Changes and Emotional Effects
Mood swings, irritability, and heightened anxiety are real pharmacological effects of the hormones used in IVF, not just a reaction to the stress of the process (though that contributes too). Estrogen and progesterone both influence brain chemistry, and the rapid, supraphysiological shifts during a stimulation cycle can amplify emotional responses. Some people describe feeling weepy or short-tempered in ways that feel out of character. These emotional effects generally track with the hormone curve, peaking near egg retrieval and easing as levels normalize afterward.
The Trigger Shot
Near the end of stimulation, you’ll receive a single “trigger shot” to finalize egg maturation before retrieval. The traditional trigger uses hCG (human chorionic gonadotropin), which produces a hormonal environment that’s quite different from what your body does naturally. After an hCG trigger, progesterone rises faster and peaks higher than in a normal cycle, and those concentrations stay elevated longer. This can intensify bloating, breast soreness, and pelvic discomfort in the days following the shot.
For patients at higher risk of ovarian hyperstimulation, clinics sometimes use an alternative trigger that works through a different hormonal pathway. This approach produces a shorter, less intense hormonal spike and significantly reduces the risk of the more serious complication described below.
Ovarian Hyperstimulation Syndrome
Ovarian hyperstimulation syndrome (OHSS) is the most significant medical risk of IVF injections. It happens when the ovaries overrespond to stimulation, becoming very swollen and leaking fluid into the abdomen and sometimes the chest cavity. Mild OHSS, with uncomfortable bloating and some nausea, is relatively common and usually managed at home with rest and fluids. Moderate OHSS occurs in roughly 3% to 6% of stimulation cycles, while severe OHSS affects 0.1% to 2%.
Symptoms of worsening OHSS include rapid weight gain (several pounds in a day or two), a visibly distended abdomen, difficulty breathing, decreased urination, and severe nausea or vomiting. Severe cases require hospitalization for fluid management and monitoring. People with polycystic ovary syndrome and those who produce a large number of eggs are at higher risk. Modern protocols have made severe OHSS less common. Clinics reduce the risk by using alternative trigger shots, adjusting medication doses based on monitoring, and sometimes freezing all embryos rather than doing a fresh transfer, since pregnancy itself can worsen OHSS.
After Egg Retrieval
The retrieval procedure itself is done under sedation and takes about 15 to 30 minutes. Afterward, cramping, spotting, and continued bloating are normal and typically mild enough to manage with rest. Most people feel significantly better within a couple of days, though some residual pelvic heaviness can linger for up to a week as the ovaries shrink back down.
If you’re doing a fresh embryo transfer, progesterone supplementation continues for weeks. This extends some side effects, particularly breast tenderness, constipation, bloating, and drowsiness, well beyond the stimulation phase. If your clinic recommends a freeze-all cycle, you’ll stop progesterone after retrieval and these symptoms resolve faster.
Long-Term Safety
The question of whether IVF medications increase cancer risk years later has been studied for decades. A large Israeli study found generally reassuring results for most cancers, with the only signal being a small, non-significant increase in ovarian cancer risk among women who underwent four or more IVF cycles. A Norwegian study, however, suggested a possible increase in breast cancer risk among women followed for the longest periods. Neither finding is definitive, and both require continued follow-up to clarify. The current evidence does not show a clear causal link between IVF medications and cancer, but the data for women who undergo many repeated cycles is still maturing.